ISCHEMIC DISEASES: MECHANISMS AND STAGES OF DEVELOPMENT

Аннотация

Ischemic diseases refer to conditions in which there is a reduction in blood supply to tissues, leading to oxygen and nutrient deprivation. These diseases are commonly associated with cardiovascular and cerebrovascular systems, manifesting as myocardial infarction, stroke, and peripheral artery disease. The pathophysiological mechanisms of ischemia include vasoconstriction, thrombosis, embolism, and atherosclerosis. Ischemic events lead to cellular damage, inflammation, and, in severe cases, irreversible tissue necrosis. Understanding the stages and mechanisms of ischemic diseases is crucial for early diagnosis and effectivetreatment strategies. Keywords: Ischemia, myocardial infarction, stroke, atherosclerosis, thrombosis, tissue necrosis, pathophysiology, cardiovascular diseases. Introduction: Ischemic diseases are a group of conditions characterized by a reduced or complete cessation of blood flow to a specific tissue or organ, which leads to an insufficient supply of oxygen and nutrients. These conditions are primarily linked to disruptions in the circulatory system, such as those caused by atherosclerosis, thrombosis, and embolism. As blood flow is compromised, cellular functions begin to falter due to the lack of oxygen and nutrients necessary for survival. The severity of ischemia depends on factors such as the duration of reduced blood flow, the extent of the affected tissue, and the abilityofthebodytocompensate for thedeficiency. Among the most common and clinically significant ischemic diseases are myocardial infarction (heart attack), stroke, and peripheral artery disease (PAD). Myocardial infarction occurs when the blood supply to the heart muscle is obstructed, typically due to a blockage in one of the coronary arteries. Stroke, one of the leading causes of death and disability globally, results from the interruption of blood flow to the brain, which can occur due to either thrombosis or embolism. Peripheral artery disease involves the narrowing or blockage of blood vessels in the limbs, often leading to pain, numbness, and in severe cases, limb loss. The pathophysiology of ischemic diseases involves intricate processes at the cellular and molecular levels. Ischemia leads to a cascade of harmful effects that damage tissues and organs. Initially, the absence of oxygen impairs cellular respiration, forcing cells to shift to anaerobic metabolism, leading to the accumulation of lactic acid and a drop in pH. This results in cellular injury, membrane dysfunction, and eventually, cell death. Moreover, the lack of blood flow also disrupts the elimination of waste products, exacerbating the ischemic environment. Prolonged ischemia triggers inflammatory responses that further contribute to tissue damage, as inflammatory cells are recruited to the site of injury, releasing harmful enzymes and reactiveoxygen species. Reperfusion, the restoration of blood flow to previously ischemic tissues, can often improve outcomes by providing oxygen and nutrients. However, this process is not without its own complications. Reperfusion injury, which occurs when blood flow is re-established after a period of ischemia, can paradoxically worsen the damage. The sudden influx of oxygen leads to the production of reactive oxygen species (ROS) that cause oxidative stress, further damaging cell membranes, proteins, and genetic material. Understanding the mechanisms underlying ischemic diseases is crucial for developing effective treatment strategies. While interventions such as 123 INTERNATIONAL MULTIDISCIPLINARY JOURNAL FOR RESEARCH & DEVELOPMENT SJIF2019:5.2222020:5.5522021:5.6372022:5.4792023:6.5632024:7,805 eISSN:2394-6334 https://www.ijmrd.in/index.php/imjrd Volume12,issue03(2025) thrombolytic therapy, angioplasty, and surgical revascularization are commonly used, preventing ischemic damage and mitigating reperfusion injury remain significant challenges. Early recognition of ischemic events and prompt medical management are key factors in improving prognosis and preventing irreversible organ damage. Furthermore, ongoing research into cellular and molecular pathways in ischemia holds promise for more targeted therapies that may offer better protection against ischemic injury and improvelong-term outcomes for patientsaffected bythese conditions. Literature review The pathophysiology of ischemic diseases has been widely studied, with substantial research focusing on understanding the underlying mechanisms, clinical manifestations, and potential therapeutic interventions. The literature reveals the complexityof ischemia at the cellular, molecular, and systemic levels. This section reviews key studies that have contributed to the current understanding ofischemicdiseases. Atherosclerosis, the progressive buildup of lipid-rich plaques in the arterial walls, is one of the primary causes of ischemia. This condition leads to narrowing and hardening of blood vessels, obstructing blood flow. Libby et al. (2019) provide an extensive re